1 citations
,
January 2022 in “Journal of The American Academy of Dermatology” Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.
December 2025 in “JMIR Dermatology” Topical finasteride is well-tolerated and satisfies most users with minimal side effects.
January 2023 in “Journal of Clinical and Diagnostic Research” Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.
January 2026 in “Dermatology Online Journal” The study of 41 products of 5% minoxidil foam revealed gender-based pricing disparities, with female-marketed products being more expensive than male-marketed ones, averaging $26.78 per bottle and $12.68 per ounce for females, compared to $22.08 per bottle and $10.46 per ounce for males. Female-marketed products were often sold in single-bottle packages, while male-marketed ones were available in cost-saving multi-bottle bundles. However, generic options showed no significant price difference between genders, indicating that generic and bulk packaging could help reduce these disparities. The study emphasizes the importance of patient education on packaging language and the need for broader availability of bulk packaging for female-marketed products to address these pricing issues.
3 citations
,
June 2023 in “Journal of dermatological treatment” Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.